BILLERICA, Mass., Dec. 18, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) today announced that it has completed its previously announced acquisition of Alicona Imaging GmbH, a leading provider of optical-based metrology products in Graz, Austria. For calendar year 2018, Alicona expects to be profitable with revenues of approximately $25 million. Financial details of the transaction were not... Read more
By GlobeNewswire, December 31, 2018, 05:30:00 AM EDT: Source Arrayit Corporation By GlobeNewswire, December 17, 2018, 05:30:00 AM EDT: Source Arrayit Corporation Sunnyvale, Dec. 17, 2018 (GLOBE NEWSWIRE) — Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports fulfillment of a clinical instrumentation contract with the United States Food and Drug Administration (FDA),... Read more
Leading Water Technology Provider and Global Water Innovation Accelerator Also Working Together to Raise Awareness of Water Solutions RYE BROOK, N.Y.–(BUSINESS WIRE)–Dec. 14, 2018– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced plans to partner with Imagine H2O, a non-profit organization that helps... Read more
BILLERICA, Mass., Dec. 13, 2018 /PRNewswire/ — Bruker Corporation and Mestrelab Research SL (www.mestrelab.com) today announced that they have entered into a strategic partnership to advance chemistry software that handles spectroscopic data and extracts and manages chemical information from a variety of analytical techniques, including for example NMR and mass spectrometry. Together the companies will focus... Read more
Stakes Claim in Emerging Spatial Genomics Space PLEASANTON, CA.—December 10, 2018—10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight... Read more
10 DEC 2018 | DARMSTADT, GERMANY genOway to acquire exclusive rights to Merck’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, announced that its life... Read more
Suzhou, China and Cambridge, UK, December 6: Abcam plc, a global innovator in life science reagents and tools, and QIAGEN (Suzhou) Translational Medicine Co., Ltd. (QIAGEN (Suzhou)) have signed a Memorandum of Understanding (MoU) agreement to jointly develop a pipeline of Companion Diagnostic (CDx) and In Vitro Diagnostic reagents and kits, to meet the specific needs... Read more
Germantown, Maryland, and Hilden, Germany, December 6, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that a clinical development program is underway with Novartis to bring to market a molecular test as a companion diagnostic to guide the use of the investigational compound BYL719 (alpelisib) in combination with fulvestrant for men... Read more
TUE, DEC 04, 2018 07:45 CET Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today entered into an agreement to acquire all outstanding shares in the privately held company PhyNexus, Inc. (PhyNexus) based in California, US, for a total purchase price of approx. USD 21.5 million (corresponding to approx. SEK 195 million[1]) financed... Read more
SAN JOSE, Calif., Dec. 4, 2018 /PRNewswire/ — PhyNexus, Inc., a privately held California corporation, announces today an agreement to be acquired by Biotage AB (Nasdaq Stockholm: BIOT.ST), strengthening its position for world-wide sales and marketing of automated lab-scale purification technology of biomolecules. Together, PhyNexus and Biotage will be able to provide their global customers an enabling automation platform... Read more